MX9304868A - 27-hidroxirapamicina, derivados de la misma y composicion farmaceutica que la contiene. - Google Patents

27-hidroxirapamicina, derivados de la misma y composicion farmaceutica que la contiene.

Info

Publication number
MX9304868A
MX9304868A MX9304868A MX9304868A MX9304868A MX 9304868 A MX9304868 A MX 9304868A MX 9304868 A MX9304868 A MX 9304868A MX 9304868 A MX9304868 A MX 9304868A MX 9304868 A MX9304868 A MX 9304868A
Authority
MX
Mexico
Prior art keywords
hydroxyrapamicine
derived
same
pharmaceutical composition
hydroxyrapamycin
Prior art date
Application number
MX9304868A
Other languages
English (en)
Spanish (es)
Inventor
Frances Christy Nelson
Original Assignee
American Home Prod
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/009,605 external-priority patent/US5256790A/en
Application filed by American Home Prod filed Critical American Home Prod
Publication of MX9304868A publication Critical patent/MX9304868A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
    • C07D498/18—Bridged systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Transplantation (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
MX9304868A 1992-08-13 1993-08-11 27-hidroxirapamicina, derivados de la misma y composicion farmaceutica que la contiene. MX9304868A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US93012492A 1992-08-13 1992-08-13
US08/009,605 US5256790A (en) 1992-08-13 1993-01-27 27-hydroxyrapamycin and derivatives thereof

Publications (1)

Publication Number Publication Date
MX9304868A true MX9304868A (es) 1994-05-31

Family

ID=26679675

Family Applications (1)

Application Number Title Priority Date Filing Date
MX9304868A MX9304868A (es) 1992-08-13 1993-08-11 27-hidroxirapamicina, derivados de la misma y composicion farmaceutica que la contiene.

Country Status (12)

Country Link
EP (1) EP0655065B1 (cg-RX-API-DMAC10.html)
JP (1) JPH08501084A (cg-RX-API-DMAC10.html)
AT (1) ATE146179T1 (cg-RX-API-DMAC10.html)
AU (1) AU5007193A (cg-RX-API-DMAC10.html)
CA (1) CA2142288A1 (cg-RX-API-DMAC10.html)
DE (1) DE69306585T2 (cg-RX-API-DMAC10.html)
DK (1) DK0655065T3 (cg-RX-API-DMAC10.html)
ES (1) ES2096941T3 (cg-RX-API-DMAC10.html)
GR (1) GR3022730T3 (cg-RX-API-DMAC10.html)
HU (1) HU221499B (cg-RX-API-DMAC10.html)
MX (1) MX9304868A (cg-RX-API-DMAC10.html)
WO (1) WO1994004540A1 (cg-RX-API-DMAC10.html)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5527907A (en) * 1993-11-19 1996-06-18 Abbott Laboratories Macrolide immunomodulators
WO1995014023A1 (en) * 1993-11-19 1995-05-26 Abbott Laboratories Semisynthetic analogs of rapamycin (macrolides) being immunomodulators
US6187757B1 (en) 1995-06-07 2001-02-13 Ariad Pharmaceuticals, Inc. Regulation of biological events using novel compounds
AU712193B2 (en) * 1995-06-09 1999-10-28 Novartis Ag Rapamycin derivatives
EP1212331B1 (en) 1999-08-24 2004-04-21 Ariad Gene Therapeutics, Inc. 28-epirapalogs
US7067526B1 (en) 1999-08-24 2006-06-27 Ariad Gene Therapeutics, Inc. 28-epirapalogs
PL216224B1 (pl) 2002-02-01 2014-03-31 Ariad Pharmaceuticals Pochodne rapamycyny zawierające fosfor, kompozycja je zawierająca oraz ich zastosowanie
JP2006516548A (ja) 2002-12-30 2006-07-06 アンジオテック インターナショナル アクツィエン ゲゼルシャフト 迅速ゲル化ポリマー組成物からの薬物送達法
EP1768662A2 (en) 2004-06-24 2007-04-04 Novartis Vaccines and Diagnostics, Inc. Small molecule immunopotentiators and assays for their detection
WO2008060546A2 (en) 2006-11-14 2008-05-22 Ariad Pharmaceuticals, Inc. Oral formulations
US8921642B2 (en) 2008-01-11 2014-12-30 Massachusetts Eye And Ear Infirmary Conditional-stop dimerizable caspase transgenic animals
CA2905229C (en) 2013-06-11 2023-10-10 Clontech Laboratories, Inc. Protein enriched microvesicles and methods of making and using the same
EP3788050B1 (en) 2018-05-01 2024-08-28 Revolution Medicines, Inc. C26-linked rapamycin analogs as mtor inhibitors
CR20240382A (es) 2018-05-01 2025-08-29 Revolution Medicines Inc ANÁLOGOS DE RAPAMICINA A C40, C28 Y C32 COMO INHIBIDORES DE MTOR (Divisional 2020-578)
EP4320101A2 (en) * 2021-04-09 2024-02-14 Revolution Medicines, Inc. Synthesis of rapamycin analog compounds
AU2023275778A1 (en) 2022-05-25 2024-12-12 Revolution Medicines, Inc. Methods of treating cancer with an mtor inhibitor

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH04230389A (ja) * 1990-07-16 1992-08-19 American Home Prod Corp ラパマイシン誘導体
US5102876A (en) * 1991-05-07 1992-04-07 American Home Products Corporation Reduction products of rapamycin

Also Published As

Publication number Publication date
ATE146179T1 (de) 1996-12-15
DK0655065T3 (cg-RX-API-DMAC10.html) 1997-02-24
DE69306585T2 (de) 1997-04-17
HUT71614A (en) 1996-01-29
JPH08501084A (ja) 1996-02-06
ES2096941T3 (es) 1997-03-16
CA2142288A1 (en) 1994-03-03
AU5007193A (en) 1994-03-15
HU9500432D0 (en) 1995-04-28
HU221499B (en) 2002-10-28
GR3022730T3 (en) 1997-06-30
DE69306585D1 (de) 1997-01-23
WO1994004540A1 (en) 1994-03-03
EP0655065A1 (en) 1995-05-31
EP0655065B1 (en) 1996-12-11

Similar Documents

Publication Publication Date Title
MX9304868A (es) 27-hidroxirapamicina, derivados de la misma y composicion farmaceutica que la contiene.
DE69325130D1 (de) N-sulfonyl-2-oxoindol-derivate mit einer affinität für die vasopressin und/oder ocytocin rezeptoren
ES2085726T3 (es) Derivado prolinico de rapamicina, su produccion y aplicacion.
IL135536A0 (en) Ortho-anthranilamide derivatives and pharmaceutical compositions containing the same
ES2085876T3 (es) Derivado de bifenilmetano, su utilizacion y composiciones farmacologicas que contienen el mismo.
IT1283588B1 (it) Miscela sinergica di agenti stabilizzanti
ES2195970T3 (es) L-ribavirina y usos de la misma.
DE69417012D1 (de) Cyclobutan-derivate als inhibitoren der squalen-synthetase und der protein-farnesyltransferase
ES2069137T3 (es) Derivados de imidazopiridina y su uso.
ES2149761T3 (es) Derivado de piridazinona.
NO943002L (no) Fosfono-oksymetyletere av taxanderivater
GR1001619B (el) Παράγωγα ινδόλης.
LU90366I2 (fr) Nasonex
RU94046018A (ru) 3-арилпиразольные производные, способ их получения и фунгицидная композиция на их основе
BG101655A (bg) Състав за защита на посеви
RU94036749A (ru) Замещенные 1-нафтилпиразол-3-карбоксамиды, способ их получения, содержащие их фармацевтические композиции и промежуточные соединения синтеза
MY128261A (en) New substituted azetidinones as anti-inflammatory and antidegenerative agents
SE9801494D0 (sv) Novel use
RU94046387A (ru) Производные пиримидина, способ их получения, фармацевтическая композиция, ее применение и промежуточные продукты
ATE282608T1 (de) Chinoxalindionen
DE69220222D1 (de) Neue D-Homo-17-oxa und D-Homo-17-aza-androstanderivate
DE69601451D1 (de) UCK14-Verbindungen
BR0013399A (pt) ésteres sdz-rad solúveis em água
ES2062228T3 (es) Derivados de cicloalquilideno.
ECSP941092A (es) Derivados de tetrahidropirano

Legal Events

Date Code Title Description
FG Grant or registration
HC Change of company name or juridical status

Owner name: SILGAN TUBES CORPORATION

MM Annulment or lapse due to non-payment of fees